NLM Logo

fezakinumab MeSH Supplementary Concept Data 2025


MeSH Supplementary
fezakinumab
Unique ID
C000629141
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C000629141
Entry Term(s)
ILV-094
Pharm Action
Dermatologic Agents
Registry Numbers
0S77U25XZ3
Heading Mapped to
*Antibodies, Monoclonal, Humanized
Frequency
10
Note
IL-22 monoclonal antibody for the treatment of atopic dermatitis
Source
J Am Acad Dermatol. 2018 May;78(5):872-881.e6.
Date of Entry
2018/12/03
Revision Date
2019/10/31
fezakinumab Preferred
ILV-094 Narrower
page delivered in 0.005s